Identity
- Trade Name
- OraQuick Advance HIV 1/2 Kit Controls FDA UDI
- Generic Name
- HIV1/HIV2 antibody IVD, control FDA UDI
- Model / Reference
- 1001-0077 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00608337000009 FDA UDI
- FDA Product Code
- MTL FDA UDI
- GMDN Term
- HIV1/HIV2 antibody IVD, control FDA UDI
Classification
- Device Class
- Class III FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: HIV1/HIV2 antibody IVD, control
OraQuick Advance HIV 1/2 Kit Controls by OraSure Technologies, Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as HIV1/HIV2 antibody IVD, control.
- VIROTROL — Bio-Rad Laboratories · Class II
- VITROS — Ortho-Clinical Diagnostics · Class I
- VIROTROL — Bio-Rad Laboratories · Class II
- VITROS — Ortho-Clinical Diagnostics · Class I
- VIROTROL — Bio-Rad Laboratories · Class II
- INSTI HIV-1/HIV-2 Control Test Kit — Biolytical Laboratories Inc · Class II
- Geenius — Bio-Rad · Class II
Cleared under the same submission
BP010047 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class III | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- OraSure Technologies, Inc.
Sources (1)
- FDA UDI 2f68422f-d6e1-406c-9d73-00bd9c7f56b7 35 fields · synced Jun 9, 2026